2022
Press Releases
-
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
-
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
-
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
-
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
2021
Press Releases
-
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020
Press Releases
-
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Early Introduction of Gluten May Prevent Celiac Disease in Children
-
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
-
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
-
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
-
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
-
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
